Abstract:Background: Equine piroplasmosis (EP) is an economically significant infection of horses and other equine species caused by the tick-borne protozoa Theileria equi and Babesia caballi. The long-term carrier state in infected animals makes importation of such subclinical cases a major risk factor for the introduction of EP into non-enzootic areas. Regulatory testing for EP relies on screening of equines by serological methods. The definitive diagnosis of EP infection in individual animals will benefit from the availability of sensitive direct detection methods, for example, when used as confirmatory assays for non-negative serological test results. The objectives of this study were to develop a real-time quantitative polymerase chain reaction (qPCR) assay for simultaneous detection of both agents of EP, perform comprehensive evaluation of its performance and assess the assay's utility for regulatory testing. Results: We developed a duplex qPCR targeting the ema-1 gene of T. equi and the 18S rRNA gene of B. caballi and demonstrated that the assay has high analytical sensitivities for both piroplasm species. Validation of the duplex qPCR on samples from 362 competitive enzyme-linked immunosorbent assay (cELISA)-negative horses from Canada and the United States yielded no false-positive reactions. The assay's performance was further evaluated using samples collected from 430 horses of unknown EP status from a highly endemic area in Brazil. This set of samples was also tested by a single-target 18S rRNA qPCR for T. equi developed at the OIE reference laboratory for EP in Japan, and a previously published single-target 18S rRNA qPCR for B. caballi whose oligonucleotides we adopted for use in the duplex qPCR. Matching serum samples were tested for antibodies to these parasites using cELISA. By the duplex qPCR, T. equi-specific 18S rRNA qPCR and cELISA, infections with T. equi were detected in 87.9% (95% confidence interval, CI: 84.5-90.7%), 90.5% (95% CI: 87.3-92.3%) and 87.4% (95% CI: 84.0-90.2%) of the horses, respectively. The B. caballi prevalence estimates were 9.3% (95% CI: 6.9-12.4%) by the duplex qPCR and 7.9% (95% CI: 5.7-10.9%) by the respective single-target qPCR assay. These values were markedly lower compared to the seroprevalence of 58.6% (95% CI: 53.9-63.2%) obtained by B. caballi-specific cELISA. The relative diagnostic sensitivity of the duplex qPCR for T. equi was 95.5%, as 359 of the 376 horses with exposure to T. equi confirmed by cELISA had parasitemia levels above the detection limit of the molecular assay. In contrast, only 39 (15.5%) of the 252 horses with detectable B. caballi-specific antibodies were positive for this piroplasm species by the duplex qPCR. Conclusions: The duplex qPCR described here performed comparably to the existing single-target qPCR assays for T. equi and B. caballi and will be more cost-effective in terms of results turnaround time and reagent costs when both pathogens are being targeted for disease control and epidemiological investigations. These validation data also support the reliability of the ema-1 gene-specific oligonucleotides developed in this study for confirmatory testing of non-negative serological test results for T. equi by qPCR. However, the B. caballi-specific qPCR cannot be similarly recommended as a confirmatory assay for routine regulatory testing due to the low level of agreement with serological test results demonstrated in this study. Further studies are needed to determine the transmission risk posed by PCR-negative equines with detectable antibodies to B. caballi.

Development of SYBR Green Ⅰ Fluorescent Quantitation Assay for Detection of Trypanosoma Equiperdum

Study of a PCR Assay for Detection of Trypanosoma equiperdum

Development of the Fluorescent Quantitative PCR for Detection of EoNPV in Ectropis Oblique

Development of a Real-Time Quantitative PCR Based on a TaqMan-MGB Probe for the Rapid Detection of Theileria haneyi

Evaluation of a Real-Time PCR Assay Based on the Single-Copy SAG1 Gene for the Detection of Toxoplasma Gondii.

Development of Real-time Fluorescence Quantitative PCR Assay for Detection of Bovine Mycobacterium paratuberculosis

Development of Nested PCR and Duplex Real-Time Fluorescence Quantitative PCR Assay for the Simultaneous Detection of Theileria equi and Babesia caballi

Development and validation of a duplex real-time PCR assay for the diagnosis of equine piroplasmosis

Development of a Dual PCR Assay for the Detection of Trypanosoma Evansi and Trypanosoma Lewisi

Establishment of a Real-time RT-PCR Assay Based on SYBR Green I for Detection of the Expression of Horse Toll-like Receptor Genes

Development of TaqMan Fluorescence Quantitative PCR for Detection of Porcine Epidemic Diarrhea Virus

Development of a SYBR-Green I real-time fluorescent quantitative PCR method for detection of pseudorabies virus.

Development and primary application of the SYBR Green I RT-qPCR assay for the detection of the transmissible gastroenteritis virus (TGEV) S gene

Development of a Real-Time Recombinase-Aided Amplification Method for the Rapid Detection of Streptococcus equi subsp. equi

Development and Preliminary Application of PCR Assay Based on 18S rRNA Gene for Detection of Theileria sp Infection

Comparison of Different PCR Assays for Detection of Theileria Equi

Development of a SYBR Green Ⅰ Real-Time PCR Assay for Detection of Porcine Hemagglutinating Encephalomyelitis Virus

Development of TaqMan-based real-time PCR assay based on the E1 genefor the quantitative detection of the Getah virus.

Polymerase Spiral Reaction (PSR) as a novel rapid colorimetric isothermal point of care assay for detection of Trypanosoma evansi genomic DNA

Development and application of SYBR Green I real-time quantitative reverse transcription PCR assay for detection of swine Getah virus

Establishment and Application of Real-Time PCR Assay Based on SYBR Green for Detection and Quantization of Cryptosporidium Parvum.